[Long term therapy of rheumatoid arthritis in children].
D000305:Adrenal Cortex Hormones / Q000009:adverse effects / Q000627:therapeutic use; D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D001171:Arthritis, Juvenile / Q000150:complications / Q000188:drug therapy* / Q000628:therapy; D001379:Azathioprine / Q000627:therapeutic use; D002648:Child; D002738:Chloroquine / Q000627:therapeutic use; D006046:Gold / Q000627:therapeutic use; D006801:Humans; D007213:Indomethacin / Q000627:therapeutic use; D008134:Long-Term Care; D008349:Manipulation, Orthopedic; D008727:Methotrexate / Q000627:therapeutic use; D010653:Phenylbutazone / Q000627:therapeutic use; D026741:Physical Therapy Modalities; D011720:Pyrazoles / Q000627:therapeutic use; D012459:Salicylates / Q000627:therapeutic use; D000074402:Synovectomy; D014606:Uveitis, Anterior / Q000209:etiology
D000305:Adrenal Cortex Hormones; D011720:Pyrazoles; D012459:Salicylates; D006046:Gold; D002738:Chloroquine; D000324:Adrenocorticotropic Hormone; D010653:Phenylbutazone; D001379:Azathioprine; D007213:Indomethacin; D008727:Methotrexate
Langzeittherapie der rheumatoiden Arthritis des Kinde.